Table 1 Demographic and baseline clinical characteristics for the 379 patients.
Mean (SD) | Number (%) | ||
|---|---|---|---|
Age at inclusion, years | 57 (15) | ||
Disease duration, months | 6.3 (3.2) | ||
Women | 241 (64) | ||
Anti CCP positive | 210 (61) | ||
RF positive | 221 (65) | ||
DAS28 | 5.07 (1.2) | ||
ESR | 38 (26) | ||
CRP, mg/L | 37 (38) | ||
HAQ, 0-3 | 0.97 (0.61) | ||
Total Sharp score (SHS) | 4.0 (8.2) | ||
Erosion score (ES) | 1.7 (3.8) | ||
Joint space narrowing score (JSN) | 2.3 (5.2) | ||
Prednisolone | 1876 (50) | ||
DMARDS | None | 77 (20) | |
Methotrexate | 155 (41) | ||
Sulfasalazine | 102 (27) | ||
Other DMARD | 44 (12) | ||
Combination | 1 (0) | ||
Biologics | 0 (0) | ||